This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Enara Bio Limited, The Francis Crick Institute Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 11 Years Active: 2025
Title: Nicola Ternette: Innovator in Cancer Research
Introduction
Nicola Ternette is a prominent inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly in the development of cancer antigens and methods for their application in treatment, prevention, and diagnosis.
Latest Patents
Ternette holds a patent for "Cancer antigens and methods." This patent discloses various polypeptides and nucleic acids encoding these polypeptides, which are useful in the treatment, prevention, and diagnosis of cancer, especially melanoma, including cutaneous melanoma and uveal melanoma.
Career Highlights
Throughout his career, Nicola Ternette has worked with notable organizations, including The Francis Crick Institute Limited and Enara Bio Limited. His work has focused on advancing the understanding and treatment of cancer, contributing to innovative solutions in the medical field.
Collaborations
Ternette has collaborated with esteemed colleagues such as George Kassiotis and David Perkins. These partnerships have further enhanced his research and development efforts in cancer therapies.
Conclusion
Nicola Ternette's work in cancer research exemplifies the impact of innovation in medicine. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment and diagnosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile